Signaling Pathways - Myosin light chain kinases (MLCKs) - SMARCA4 - Tie-2 - EAA receptor
清除全部
-
B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂 -
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂 -
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂 -
B7744 PFI 3Target: Protein polybromo-1|SMARCA4|SMARCA2Summary: Polybromo 1和SMARCA4抑制剂 -
B6227 Kynurenic acid中文名: 犬尿酸Target: EAA receptorSummary: 广谱EAA拮抗剂 -
B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂 -
B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂 -
A5979 Tie2 kinase inhibitor中文名: Tie2激酶抑制剂Target: Tie-2Summary: Tie-2(Tie2 )抑制剂 -
A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: 肌球蛋白轻链激酶抑制剂